Ignite Creation Date:
2024-05-06 @ 9:17 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02946476
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2016-10-25
Brief Title:
Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients
Sponsor:
Ospedale Maggiore Di Trieste
Organization:
Ospedale Maggiore Di Trieste
Study Overview
Official Title:
Prevalence and Prognostic Impact of Noncardiac Comorbidities in Heart Failure Outpatients With Preserved and Reduced Ejection Fraction A Community-Based Study
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NCC-HF
Brief Summary:
To better understand the public health prognostic impact of noncardiac chronic illnesses we explored the attributable risk of noncardiac comorbidities on outcomes between heart failure patients with reduced ejection fraction HFREF and heart failure patients with preserved ejection fraction HFpEF in a large contemporary heart failure HF population The adjusted hazard ratio HR and the population attributable risk were used to compare the contributions of 15 noncardiac comorbidities to adverse outcome The comorbidities that contributed to high attributable risk were anemia chronic kidney disease chronic obstructive pulmonary disease diabetes mellitus and peripheral artery disease These findings were similar for HFrEF and HFpEF groups Interaction analysis confirmed similar results
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None